Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TP53 | P04637 | 2/20 | 0.64 |
| ▸ | MAPT | P10636 | 2/20 | 0.64 |
| ▸ | HPGD | P15428 | 2/20 | 0.64 |
| ▸ | TSHR | P16473 | 2/20 | 0.64 |
| ▸ | MEN1 | O00255 | 2/20 | 0.64 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.64 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.64 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.64 |
| ▸ | PPARG | P37231 | 1/20 | 0.64 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.64 |
| ▸ | PLA2G2A | P14555 | 14/20 | 0.47 |
| ▸ | PLA2G10 | O15496 | 4/20 | 0.44 |
| ▸ | PLA2G1B | P04054 | 3/20 | 0.44 |
| ▸ | PLA2G5 | P39877 | 3/20 | 0.44 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10049658 | 1.00 | TP53 (0.64) | TP53MAPTHPGDTSHRMEN1 | |
| SCHEMBL16489885 | 0.99 | ALDH1A1 (0.65) | TP53MAPTHPGDTSHRMEN1 | |
| SCHEMBL6859802 | 0.90 | TP53 (0.55) | TP53MAPTHPGDTSHRMEN1 | |
| SCHEMBL6858505 | 0.90 | TP53 (0.55) | TP53MAPTHPGDTSHRMEN1 | |
| SCHEMBL6856647 | 0.86 | ALDH1A1 (0.59) | TP53MAPTHPGDTSHRMEN1 | |
| SCHEMBL11995406 | 0.85 | ALDH1A1 (0.82) | TP53MAPTHPGDTSHRMEN1 | |
| SCHEMBL16489888 | 0.84 | ALDH1A1 (0.61) | TP53MAPTHPGDTSHRMEN1 | |
| SCHEMBL15159444 | 0.84 | ALDH1A1 (0.85) | TP53MAPTHPGDTSHRMEN1 | |
| SCHEMBL6859810 | 0.84 | KMT2A (0.59) | TP53MAPTHPGDTSHRMEN1 | |
| SCHEMBL23269736 | 0.82 | ALDH1A1 (0.76) | TP53MAPTHPGDTSHRMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20150051316-A1 | EPOXY COMPOUND HAVING ALKOXYSILYL GROUP, COMPOSITION AND HARDENED MATERIAL COMPRISING SAME, USE FOR SAME, AND PRODUCTION METHOD FOR EPOXY COMPOUND HAVING ALKOXYSILYL GROUP | KOREA INSTITUTE OF INDUSTRIAL TECHNOLOGY (KR) | 2015-02-19 | — | — | US | disclosed |
| US-20150051316-A1 | EPOXY COMPOUND HAVING ALKOXYSILYL GROUP, COMPOSITION AND HARDENED MATERIAL COMPRISING SAME, USE FOR SAME, AND PRODUCTION METHOD FOR EPOXY COMPOUND HAVING ALKOXYSILYL GROUP | KOREA INSTITUTE OF INDUSTRIAL TECHNOLOGY (KR) | 2015-02-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150051316-A1 | EPOXY COMPOUND HAVING ALKOXYSILYL GROUP, COMPOSITION AND HARDENED MATERIAL COMPRISING SAME, USE FOR SAME, AND PRODUCTION METHOD FOR EPOXY COMPOUND HAVING ALKOXYSILYL GROUP | ESD, ELL, ASH2L | TP53 4626/4885MAPT 1012/4885HPGD 2578/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.